Sam Brusco
Associate Editor at (ODT) Orthopedic Design & Technology Magazine
Lover of MedTech, music, satire, and sci-fi. Hoping someday for an overlap. Associate Editor of MPO & ODT—views expressed are my own.
Articles
-
3 days ago |
mpo-mag.com | Sam Brusco
AVNA, a manufacturer of medical device components and subassemblies, has relocated and expanded its Costa Rice operations to the new Evolution Free Zone, in Grecia Costa Rica. The investment totaled $5.5 million and represented a 116% increase of production capacity. The opening positions the company as the anchor tenant of the business part and reinforced its commitment to growth in Costa Rica.
-
3 days ago |
odtmag.com | Sam Brusco
Pixee Medical, a pioneer in augmented reality (AR) navigation for orthopedic surgery, has earned U.S. Food and Drug Administration (FDA) 510(k) cleaqrance for Knee+ NexSight, its new AR guidance solution for total knee arthroplasty (TKA). This next-gen AR tool was designed to address the burgeoning market of ambulatory surgical centers (ASCs). Knee+ NexSight was developed in collaboration with orthopedic surgeons and built on a platform with over 10,000 successful procedures worldwide.
-
3 days ago |
mpo-mag.com | Sam Brusco
Resmed has appointed Salli Schwartz as its new chief investor relations officer, effective April 21. Schwartz will lead the company’s global investor relations and report to chairman and CEO Mick Farrell. Schwartz touts over two decades of experience in finance roles at healthtech and financial services organizations. She joins Resmed from Illumina, where she was head of investor relations.
-
3 days ago |
mpo-mag.com | Sam Brusco
Orchestra BioMed has been granted Breakthrough Device Designation (BDD) from the U.S. Food and Drug Administration (FDA) for its atrioventricular interval modulation (AVIM) therapy.
-
3 days ago |
mpo-mag.com | Sam Brusco
Biolinq, a company pioneering precision, multi-analyte sensors to improve metabolic health, has received a $100 million Series C financing led by Alpha Wave Ventures. Participation also occurred from existing investors RiverVest Venture Partners, AXA IM Alts, LifeSci Venture Partners, M Ventures, Hikma Ventures, Aphelion Capital, Taisho Pharmaceutical and Features Capital.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 267
- Tweets
- 875
- DMs Open
- No
RT @ODTmagazine: .@Medtronic_Spine VP and GM Carlton Weatherby discusses spinal technology with associate editor @SamISureAm. #spinesurgery…
A spotlight on the latest technologies from #spine companies of all sizes. #spinesurgery @VIVEX_Biologics @augmedics @NuVasiveInc | https://t.co/w2DxTsZDxd https://t.co/83Loqr7xFw
.@DraganflyInc's pandemic drone should help health officials fixate on outbreaks immediately as it soars above communities. #COVID19 https://t.co/Zf2y2JYVRn